Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Lilly | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Lilly

Revenues up 6% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lilly
 
3Q Revenues: $5.8 billion (+6%)

3Q Earnings: $1.2 billion (-9%)

YTD Revenues: $17.3 billion (+4%)

YTD Earnings: $4.0 billion (+21%)

Comments: Revenue in the U.S. increased 11% to $3.3 billion in the quarter, while revenue outside the U.S. was flat at $2.5 billion, impacted by the depreciation of the Japanese yen. Growth was driven by Humalog, up 7% to $616 million, Alimta, up 7% to $690.5 million, and Forteo, up 6% to $306.7 million. Zyprexa sales were down 26% to $278.7 million and Cymbalta was down 11% to $1.4 billion, due to generic competition. Animal Health revenue was up 11% to $530.3 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters